July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Retinal preservation following lateral ventricle injection of AAV9-Cln6 into mouse model for Batten disease
Author Affiliations & Notes
  • Bin Lu
    Board of Governors Regenerative Medicine Institute, Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, California, United States
  • B Meyerink
    Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, South Dakota, United States
  • K A White
    Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, South Dakota, United States
  • J M Weimer
    Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, South Dakota, United States
    Pediatrics of Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, United States
  • C N Svendsen
    Board of Governors Regenerative Medicine Institute, Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, California, United States
    David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Shaomei Wang
    Board of Governors Regenerative Medicine Institute, Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, California, United States
    David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Bin Lu, None; B Meyerink, None; K A White, None; J M Weimer, None; C N Svendsen, None; Shaomei Wang, None
  • Footnotes
    Support  The Charlotte and Gwenyth Gray Foundation
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3418. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bin Lu, B Meyerink, K A White, J M Weimer, C N Svendsen, Shaomei Wang; Retinal preservation following lateral ventricle injection of AAV9-Cln6 into mouse model for Batten disease. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3418. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Batten disease (neuronal ceroid lipofusinosis-NCLs) are a group of neurodegenerative lysosomal storage disease mainly affecting children. Loss of vision is also a major symptom in CNLs. There is no treatment yet. Mutation in Cln6 causes variant late-infantile NCL with vision impairment. Here, we investigate photoreceptor preservation following AAV8-Cln6 intra-ventricle delivery.

Methods : Wild type and homozygous Cln6-mutant mice (Cln6nclf) on C57BL/6J backgrounds were used for all studies and were housed under identical conditions. Mice received a single intracerebroventricular (ICV) injection of either PBS (n=18) or scAAV9.CB.CLN6 (n=18) (5x1010 vg/animal in 4 μL volume) at postnatal day one (the day after birth) following hypothermia sedation. Animals were monitored continuously until fully recovered from sedation and daily thereafter. Subretinal injection: AAV9-Cln6 was injected at 3 (n=11) and 6 months (n=10), AAV-GFP (n=10) or PBS (n=10) injection was used as control. Eyeballs were collected at 3-, 6- and 9-month time points. Retinal cryostat sections were processed for histology and immunofluorescence.

Results : ICV delivery of scAAV9.CB.CLN6 at P1 significantly rescue photoreceptors (8-10 layers) at both 6-and 9-month time points, compared with 0-3 layers in PBS treated eyes. The preservation of photoreceptors at the central part of the eye is more evidence than peripheral part. It is noted that degeneration rate was uneven in these mice with nasal and dorsal part of the retina degenerating slower than the temporal and ventral part of the retina. The Subretinal injection of scAAV9.CB.CLN6 did not rescue photoreceptors, similar to AAV-GFP and PBS treated retinas. In addition, T cell infiltration was frequently observed in mice received injection at 6 months of age. There is advanced retinal degeneration with age, secondary pathology including inner retinal neuron migration, loss of retinal neurons were observed in 9 month old mice.

Conclusions : ICV delivery of scAAV9.CB.CLN6 at P1 can significantly prevent photoreceptors from degeneration, especially the central part of the retina. The peripheral part of retina still underwent progressive degeneration, which needs to be further studied. In addition, translational delivery of Cln6 at adult mice to examine photoreceptor preservation and correlate with functional evaluation is under investigation.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×